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Biliary Infections: Cholecystitis 
Background 
1. Definitions  
o Acute cholecystitis  
 Clinical syndrome of RUQ pain, fever and leukocytosis due to 
gallbladder inflammation  
 Usually caused by gallstones in cystic duct 
o Acalculous cholecystitis  
 Associated with biliary stasis from burns, major surgery or sepsis 
 Gallbladder inflammation without gallstones  
 Usually in critically ill patients, carries high morbidity and mortality 
o Ascending cholangitis  
 Bile duct bacterial infection caused by biliary flow obstruction 
 Usually due to choledocholithiasis (common duct stones)  
 
Pathophysiology 
1. Pathology  
o Acute cholecystitis  
 95% of cases due to gallstones or biliary sludge obstructing cystic 
duct
7,8,9
  
 Prolonged obstruction, cholesterol-supersaturated bile and gallstone-
induced trauma trigger acute gallbladder wall inflammatory 
response and edema mediated by PGE2 & 6-keto PGF1 alpha 
 Gallbladder dysmotility develops, distention and increased 
intraluminal pressure compromise blood flow to the mucosa 
 Bacterial contamination may develop as a late sequelae (E. coli most 
common) 
o Acalculous cholecystitis  
 Stasis and obstruction in setting of stress, trauma, shock, TPN  
 Believed to be from direct ischemic compromise of gallbladder 
2. Incidence, prevalence  
o 10% of people in Western society 
o 80% asymptomatic 
o 1-3% of patients with symptomatic gallstones develop acute cholecystitis 
3. Risk factors  
o Gallstone risk factors  
 Obesity, rapid weight loss, childbearing, meds, postmenopausal 
estrogens, increasing age, hereditary 
o Biliary colic  
 30% of patients with biliary colic develop acute cholecystitis within 
2 years 
o Acalculous cholecystitis  
 Severe illness  
 Sepsis, major surgery, severe burns, multisystem organ failure, 
prolonged TPN, sickle cell disease, Salmonella infection 
 Elderly patients  
 Likely an ischemic process, similar risk factors as atherosclerosis 
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o Gender  
 <50 yo  
 3x more common in women 
 >50 yo  
 Equal risk for both genders 
4. Morbidity/mortality  
o Spontaneous resolution in 7-10 days if untreated in majority 
o Complications  
 Gallbladder gangrene (20% of untreated) 
 Perforation of gallbladder (2% of untreated)  
 Occurs after gangrene 
 Usually localized with pericholecystic abscess 
 Less commonly into peritoneum leading to generalized 
peritonitis 
 Cholecystoenteric fistula  
 Perforation of gallbladder into duodenum or jejunum 
 Gallstone ileus  
 Passage of gallstone through cholecystoenteric fistula 
leading to mechanical small bowel obstruction 
 Emphysematous cholecystitis  
 Secondary infection with gas-forming organisms like 
Clostridia perfringens, E. coli, staph, strep, klebsiella and 
pseudomonas 
 30% cases are diabetics 
 Heralds the development of gangrene, perforation, and other 
complications 
 
Diagnostics 
1. History/symptoms  
o RUQ/epigastric pain  
 Constant, severe, radiating to back/R shoulder, lasting > 3 hr 
o Fatty food ingestion >1 hr before onset of pain 
o Fever 
o Malaise 
o Anorexia 
o Nausea, vomiting 
2. Physical exam  
o Febrile, tachycardia 
o Patients may lie motionless  
 Movement aggravates pain 
o Guarding  
 Voluntary and involuntary 
o Palpable gallbladder in 30-40% 
o Jaundice in 15% 
o + Murphy's sign  
 Severe RUQ pain with inspiration 
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3. Diagnostic tests  
o Laboratory evaluation  
 Leukocytosis with left shift 
 If total bilirubin and alk phos elevated, possible cholangitis or 
gallstone in common bile duct (choledocholithiasis) 
o Diagnostic imaging (SOR:B) 
 Ultrasound is first choice imaging modality  
 81-100% sensitivity and 60-100% specificity in detecting 
acute cholecystitis  
 84% sensitivity and 99% specificity in detecting gallstones 
>2 mm 
 Findings include distended gallbladder with pericholecystic 
fluid, gallbladder wall edema (>4 mm), presence of 
gallstones, positive sonographic Murphy's sign 
 HIDA scan  
 Gold standard  
 Does have problems with acalculous cholecystitis 
and cannot view pericholecystic structures 
 Indicated if ultrasound nondiagnostic 
 97% sensitivity and 90% specificity in detecting cystic duct 
obstruction  
 Positive test shows absence of radiolabeled substance filling 
the gallbladder due to cystic duct obstruction, usually from 
edema of acute cholecystitis or obstructive stone 
o Abdominal CT  
 Usually unnecessary given above modalities 
 More sensitive and specific than US 
 Findings include gallbladder wall edema, pericholecystic stranding 
and fluid, and high attenuation bile 
 Useful to rule out complications  
 Gallbladder perforation 
 Emphysematous cholecystitis 
o Plain abdominal radiographs  
 Radiopaque gallstones in 10% of cases 
 Gas within gallbladder wall in emphysematous cholecystitis usually 
from E.coli or Clostridium 
 
Differential Diagnosis 
1. Key DDx  
o Biliary colic  
 Transient obstruction of cystic duct, pain subsides after <3 hrs and 
patient feels well, usually afebrile 
o Choledocholithiasis  
 Obstruction of the common bile duct by a stone 
 Pain, jaundice, LFT elevations 
o Ascending cholangitis  
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 Acute obstruction of biliary tree causing infection and inflammation; 
patients appear toxic, fevers and chills, jaundice, leukocytosis, 
elevated alk phos and total bilirubin 
o Chronic cholecystitis  
 Chronic inflammation after recurrent acute cholecystitis, thickened 
gallbladder, long-standing postprandial discomfort 
o Hepatitis  
 Jaundice, fever, + hepatitis serologies 
2. Extensive DDx  
o Other GI causes of abdominal pain  
 PUD, gastritis, pancreatitis, infectious colitis, diverticulitis, IBD, 
SBO, appendicitis, DKA gastroenteritis 
 Spontaneous bacterial peritonitis, amoebic hepatic abscess 
o Non-GI causes of abdominal pain  
 MI, intestinal ischemia, renal colic, pyelonephritis, PID, right lower 
lobe 
 
Acute Treatment (SOR:B) 
1. Admit to hospital 
2. Conservative treatment for 24-48 hr then cholecystectomy  
3. NPO, NG tube if vomiting 
4. IV hydration, correct electrolyte abnormalities 
5. Analgesia  
o Ketorolac 30-60 mg IM (adjusted for age and renal function) 
o IV narcotic analgesia may be required 
6. Antibiotics  
o Benefit unclear 
o Cover enterococcus, anaerobes and gram-negatives  
o Administer if  
 Systemic signs: fever, tachycardia, hypotension 
 No improvement after 12 hr conservative tx 
o Ampicillin 2 g IV q4hr plus gentamicin (dosed by weight and renal 
function)  
o Piperacillin/tazobactam 3.375 g IV q6 or 4.5g IV q8hr 
o Ampicillin sulbactam 3 g IV q6hr 
o Ticarcillin clavulanate 3.1 g IV q6hr 
o 3rd gen cephalosporin  
 Ceftriaxone 1 g IV q24hr + metronidazole 500 mg IV q8hr 
o Fluoroquinolones  
 Ciprofloxacin 400 mg IV q12hr / levofloxacin 500 mg IV q24hr 
AND metronidazole 500 mg IV q8hr 
o If life-threatening, imipenem 0.5 g IV q6hr or meropenem 1 g IV q8hr or 
ertapenem 1 g q24hr 
7. Immediate cholecystectomy  
o If patient appears toxic, or gangrene or perforation suspected 
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Further Management (SOR:C) 
1. Low surgical risk patients  
o 24-48 hr supportive care followed by laparoscopic cholecystectomy  
o Early lap chole has some surgical risk as late lap chole, but lower cost and 
lower morbidity by reducing recurrent Sx/readmission 
2. High surgical risk patients  
o Severe cardiovascular or pulmonary disease, or patients with sepsis 
o Conservative management  
o If fail to improve  
 Percutaneous cholecystostomy to drain gallbladder plus continued 
antibiotics 
 Once inflammation resolved, elective cholecystectomy 
 If not surgical candidates  
 Gallstone dissolution therapy with ursodiol via 
cholecystostomy catheter 
3. Contraindications for laparoscopic cholecystectomy  
o Cirrhosis, coagulopathy, pancreatitis, pregnancy, morbid obesity, severe 
cardiorespiratory insufficiency, signs of gallbladder perforation 
 
Prognosis (SOR:B) 
1. Mortality for single episode of acute cholecystitis is 3%  
o <1% mortality in young, otherwise healthy patients 
o 10% mortality in high-risk patients or those with complications 
 
Prevention (SOR:C) 
1. Prevention of gallstones 
2. NSAIDs for biliary colic  
o Single dose ketorolac 30-60 mg IM (adjusted for age and renal function) 
followed by ibuprofen 400 mg PO for subsequent attacks 
o Indomethacin and diclofenac have shown promise in some studies 
o May reduce progression to acute cholecystitis  
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